« Previous
Next »
Titles
- PCSK9 inhibitors for treatment of high cholesterol: effectiveness, value, and value-based price benchmarks : final report1
- Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer: effectiveness and value : final evidence report1
- Prophylaxis for hereditary angioedema with lanadelumab and C1 Inhibitors: effectiveness and value : final evidence report1
- Sterile water should not be given "freely"1
- Targeted immune modulators for rheumatoid arthritis: effectiveness & value : evidence report1
- Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: effectiveness and value : condition update : final evidence report1
- The comparative clinical effectiveness and value of simeprevir and sofosbuvir in the treatment of chronic hepatitis C infection: a technology assessment : final report1
- Timely treatment of stroke symptoms in the emergency department may improve outcomes1
- Voretigene neparvovec for biallelic RPE65-mediated retinal disease: effectiveness and value : final evidence report1